JFG
Jefferies Financial Group Portfolio holdings
AUM
$10.9B
1-Year Est. Return
15.76%
1 Year Est. Return
+15.76%
AUM
$6.06B
AUM Growth
+$261M
(+4.5%)
Holding
1,599
Top Buys
| 1 | +$308M | |
| 2 | +$61.2M | |
| 3 | +$55.5M | |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$52.8M |
| 5 |
Capital One
COF
|
+$52.6M |
Top Sells
| 1 | +$109M | |
| 2 | +$74.4M | |
| 3 | +$67.7M | |
| 4 |
Nasdaq
NDAQ
|
+$60.7M |
| 5 |
Goldman Sachs
GS
|
+$60.1M |
Sector Composition
| 1 | Healthcare | 14.44% |
| 2 | Financials | 12.53% |
| 3 | Technology | 10.24% |
| 4 | Industrials | 7.66% |
| 5 | Energy | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
PG&E
PCG
$36.2B
| $3.48M | 0.03% |
249,592
+17,089
|
|
||
252
Airbnb
ABNB
$74B
| $3.47M | 0.03% |
26,218
+18,789
|
|
||
253
Stellantis
STLA
$30B
| $3.41M | 0.03% |
340,306
+103,428
|
|
||
254
Danaher
DHR
$156B
| $3.38M | 0.03% |
17,087
+7,936
|
|
||
255
DocGo
DCGO
$105M
| $3.37M | 0.03% |
2,144,456
+115,000
|
|
||
256
Bristol-Myers Squibb
BMY
$95B
| $3.35M | 0.03% |
72,433
+22,282
|
|
||
257
iShares Silver Trust
SLV
$24.7B
| $3.31M | 0.03% |
+100,763
|
|
||
258
Exelixis
EXEL
$11.2B
| $3.31M | 0.03% |
+75,000
|
|
||
259
CME Group
CME
$103B
| $3.3M | 0.03% |
11,981
-28,605
|
|
||
260
American Express
AXP
$246B
| $3.27M | 0.03% |
10,265
+2,202
|
|
||
261
Invesco
IVZ
$10.5B
| $3.26M | 0.03% |
206,451
-744,998
|
|
||
262
iShares Core S&P Total US Stock Market ETF
ITOT
$78.2B
| $3.22M | 0.03% |
23,825
-810
|
|
||
|
BCYC
263
Bicycle Therapeutics
BCYC
$450M
| $3.2M | 0.03% |
461,100
+52,211
|
|
||
264
Motorola Solutions
MSI
$63.3B
| $3.2M | 0.03% |
7,615
+4,900
|
|
||
265
Astronics
ATRO
$1.86B
| $3.2M | 0.03% |
+95,616
|
|
||
266
Union Pacific
UNP
$132B
| $3.18M | 0.03% |
13,800
+9,148
|
|
||
267
Maplebear
CART
$10.8B
| $3.17M | 0.03% |
+70,000
|
|
||
268
Texas Instruments
TXN
$145B
| $3.16M | 0.03% |
15,222
-64,995
|
|
||
269
T. Rowe Price
TROW
$22.2B
| $3.14M | 0.03% |
32,500
-31,727
|
|
||
270
Brown-Forman Class B
BF.B
$13.2B
| $3.11M | 0.03% |
115,700
+92,500
|
|
||
|
JBTM
271
JBT Marel
JBTM
$7B
| $3.09M | 0.03% |
+25,720
|
|
||
272
Trade Desk
TTD
$20.3B
| $3.08M | 0.03% |
42,807
+24,863
|
|
||
273
Theravance Biopharma
TBPH
$881M
| $3.05M | 0.03% |
276,887
+255,455
|
|
||
274
Cabaletta Bio
CABA
$222M
| $3.04M | 0.03% |
+1,997,208
|
|
||
275
Applied Materials
AMAT
$180B
| $3.03M | 0.03% |
16,525
-3,345
|
|